Evaluation of socio-demographic and clinical characteristics of PCOS patients attending a tertiary care institute in Colombo

Table 3 Study group characteristics

	Minimum	Maximum	Mean	Standard. Deviation
Age	18	44	26.7	6.7
Birth Weight (Kg)	1.5	5.1	2.8	0.65
Pubarche age	9	18	11.9	1.7
Menarche age	9	18	12.2	1.7
Hirsutism (Ferriman Gallway Score)	3	26	14.5	5.5
LH Level (IU/L)	1.1	23.1	10.2	5.8
FSH Level (IU/L)	1.1	16.9	5.9	2.5
Serum Total Testosterone (ng/dL)	8.6	193	63.8	40.9
FBS (mg/dL)	66	345	96.8	42.9
PPBS (mg/dL)	77.8	172	103.8	27.2
HbA1C (mg/dL)	4.5	10.5	5.7	1.2
TC (mg/dL)	130	323	209.8	50.5
TG (mg/dL)	50	366	132.5	67.3
LDL-C (mg/dL)	62	141	133.7	42.5
AST (U/L)	11	214	35.5	37.2
ALT (U/L)	10	148	38.2	31.8
Serum fasting insulin (mIU/ml)	3.8	44.9	14.6	10.0
Fat % on whole body DEXA	29.6	47.9	39.0	4.6

Lab Reference ranges
LH (Adult females)- Follicular phase 1.9–12.5 IU/L, Midcycle phase 8.7- 76.3 IU/L, Luteal phase 0.5- 16.9 IU/L, Post menopausal 15.9–54 IU/L
FSH (Adult females)- Follicular phase 2.5- 10.2 IU/L, Midcycle phase 3.4 -33.4 IU/L, Luteal phase 1.5–9.1 IU/L, Post menopausal 23–116.3 IU/L
Total Testosterone 14–76 ng/dL
FBS 70–110 mg/dL, PPBS < 140 mg/dL, HbA1c ≥ 6.5%- Diabetes, 5.7%-6.4%- Prediabetes, < 5.7%- Normal, TC < 200 mg/dL, TG < 150 mg/dL, LDL < 100 mg/dL, AST < 35 U/L, ALT < 35 U/L, Serum fasting insulin 2–20 mIU/ml

ISSN: 1472-6823